Kubota Pharmaceutical Holdings Co.,Ltd. [4596.T]
TOKYO, Jul 07 (Pulse News Wire) – Kubota Pharmaceutical Holdings CO.,LTD. (4596.T) announced that the exercise of its 38th tranche subscription rights, allocated to EVO FUND, was completed as of July 7, 2026.
The company had resolved to issue these subscription rights during a board meeting held on November 14, 2025, which was subsequently approved at a special shareholders' meeting on December 19, 2025. A total of 450,000 subscription rights were initially issued, with 450,000 being exercised, leaving none remaining.
🟢 Confidence: High AI-translated content.